Changing the rules of the game. Steve Bates, CEO, BIA

Get the Flash Player to see this video.

 

Changing the rules of the game. Steve Bates, CEO, BIA

Steve Bates, CEO, BIA talks to Nigel Borshell about their involvement in the European Adaptive Licensing scheme and the UK's Early Access scheme and how these initiatives can help companies find a new path to market or way to bring their drugs forward which will ultimately benefit patients.

The UK is one of the best places in the world for life sciences, on a par with premier life science destinations such as Boston, San Francisco, San Diego and Singapore. Focussing on the need for access to finance for the British Biotec industry and regulatory reform for drug development and drug discovery the BIA works with other parties helping to shape a better environment for the UK bioscience sector. Steve Bates, CEO, BIA talks to Nigel Borshell about their involvement in the European Adaptive Licensing scheme and the UK's Early Access scheme and how these initiatives can help companies find a new path to market or way to bring their drugs forward which will ultimately benefit patients.